INTERCEPT PHARMACEUTICALS INC 4
4 · INTERCEPT PHARMACEUTICALS INC · Filed May 9, 2013
Insider Transaction Report
Form 4
TALLARIGO LORENZO
Director
Transactions
- Award
Options to Purchase Common Stock
2013-05-07+2,450→ 2,450 totalExercise: $31.90Exp: 2023-05-07→ Common Stock (2,450 underlying) - Award
Common Stock
2013-05-07+1,640→ 1,640 total
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock units ("RSUs") granted on May 7, 2013, with each RSU representing the contingent right to receive one share of common stock upon vesting of the RSU. 100% of the shares of common stock underlying these RSUs (i.e. 1,640 shares) will vest on May 7, 2014, the one year anniversary of the grant date, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the "2012 Plan").
- [F2]100% of the shares of common stock underlying this option (i.e. 2,450 shares) will vest on May 7, 2014, the one year anniversary of the grant date, subject to the terms and conditions of the award and the 2012 Plan.